secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001558370-23-009374
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical Q1 revenue $111K, net loss $2.5M; guides Q2 revenue above prior year
--------------------------------------------------------------------------------

- Q1 2023 revenue $111K, down from $190K in Q1 2022 due to lower Canada sales and one-time prior year delivery.
- Net loss $2.5M ($0.09 per share) vs $4.3M ($1.15 per share) in Q1 2022; operating loss $3.8M.
- Cash used in operations $3.2M, down from $4.7M; cash balance $11.3M, no debt.
- Received Health Canada authorization for PoNS for gait deficit due to mild/moderate stroke symptoms.
- Signed exclusive distribution agreement with HealthTech Connex for Vancouver/Fraser Valley region.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837023009374/0001558370-23-009374-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837023009374/hsdt-20230511x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-009374

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer